Showing results 1 to 20 of 32
next >
| Issue Date | Title | Author(s) |
| 2019 | AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma | Leonard, John P.; Trneny, Marek; Izutsu, Koji; Fowler, Nathan H.; Hong, Xiaonan; Zhu, Jun; Zhang, Huilai; Offner, Fritz; Scheliga, Adriana; Nowakowski, Grzegorz S.; Pinto, Antonio; Re, Francesca; Fogliatto, Laura Maria; Scheinberg, Phillip; Flinn, Ian W.; Moreira, Claudia; Cabecadas, Jose; Liu, David; Kalambakas, Stacey; Fustier, Pierre; Wu, Chengqing; Gribben, John G.; Calaminici, Maria; Copie-Bergman, Christiane; Lopez-Guillermo, Armando; O'Connor, Owen; Williams, Michael; Suciu, Stefan; Levine, Benjamin; Kern, Julie |
| 2018 | Baseline Characteristics of 3046 Non-Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP) | Song, Yuqin; Zhang, Huilai; Yang, Haiyan; Liu, Aichun; Cen, Xinan; Zhu, Jun; Wen, Yi |
| 2018 | Baseline Characteristics of 412 Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP) | Zhang, Huilai; Song, Yuqin; Liu, Aichun; Yang, Haiyan; Cen, Xinan; Zhu, Jun; Wen, Yi |
| 2017 | Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China | Shi, Yuankai; Jia, Bo; Xu, Wei; Li, Wenyu; Liu, Ting; Liu, Peng; Zhao, Weili; Zhang, Huilai; Sun, Xiuhua; Yang, Haiyan; Zhang, Xi; Jin, Jie; Jin, Zhengming; Li, Zhiming; Qiu, Lugui; Dong, Mei; Huang, Xiaobing; Luo, Yi; Wang, Xiaodong; Wang, Xin; Wu, Jianqiu; Xu, Jingyan; Yi, Pingyong; Zhou, Jianfeng; He, Hongming; Liu, Lin; Shen, Jianzhen; Tang, Xiaoqiong; Wang, Jinghua; Yang, Jianmin; Zeng, Qingshu; Zhang, Zhihui; Cai, Zhen; Chen, Xiequn; Ding, Kaiyang; Hou, Ming; Huang, Huiqiang; Li, Xiaoling; Liang, Rong; Liu, Qifa; Song, Yuqin; Su, Hang; Gao, Y |
| 15-Nov-2022 | Clinical Characteristics and Outcomes of Follicular Lymphoma Patients with Extranodal Involvement: Analysis of a Series of 1090 Cases in China | Lin, Zhijuan; Zha, Jie; Yi, Shuhua; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Fan, Liyuan; Yu, Haifeng; Zheng, Zhong; Xu, Wei; Chen, Feili; Xie, Ying; Chen, Bi-yun; Zhang, Huilai; Wang, Li; Ding, Kaiyang; Li, Wenyu; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing |
| 23-Aug-2021 | Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China | Zha, Jie; Fan, Liyuan; Yi, Shuhua; Yu, Haifeng; Zheng, Zhong; Xu, Wei; Deng, Manman; Lin, Zhijuan; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Chen, Feili; Xie, Ying; Chen, Biyun; Zhang, Huilai; Wang, Li; Ding, Kaiyang; Li, Wenyu; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing |
| Sep-2021 | Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia | Lee, Yong-Pyo; Yoon, Sang Eun; Song, Yuqin; Kim, Seok Jin; Yoon, Dok Hyun; Chen, Tsai-Yun; Koh, Young Il; Kang, Ka Won; Lee, Ho Sup; Wei, Kevin Tay Kuang; Lim, Soon Thye; Poon, Michelle; Irawan, Cosphiadi; Zhao, Weili; Do, Young Rok; Lee, Mark Hong; Ng, Soo Chin; Lee, Won-Sik; Guo, Ye; Zhang, Huilai; Kang, Hye-Jin; Yun, Hwan Jung; Kim, Hyo Jung; Lung, Daryl Tan Chen; Kwak, Jae-Yong; Han, Jae Joon; Mun, Yeung-Chul; Oh, Sung Yong; Shim, Hyeok; Kwon, Jung Hye; Sohn, Byeong Seok; Park, Seong Kyu; Jo, Jae Cheol; Ko, Young Hyeh; Jun, Zhu; Kim, Won Seog |
| 2-Nov-2023 | Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma | Zha, Jie; Chen, Qinwei; Zhang, Wei; Jing, Hongmei; Ye, Jingjing; Yu, Haifeng; Yi, Shuhua; Li, Caixia; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Lin, Zhijuan; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing |
| May-2021 | Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma | Liu, Dan; Ma, Chunguang; Lu, Ping; Gong, Jifang; Ye, Dingwei; Wang, Siyang; Peng, Peijian; Bai, Yuxian; Song, Yuqin; Chen, Jianhua; Jiang, Ou; Zhang, Guojun; Ba, Yi; Chen, Li; Pan, Jianji; Li, Qi; Zhang, Liling; Gu, Shanzhi; Yin, Xianli; Cao, Bangwei; Han, Weiqing; Dong, Haiying; Guo, Jianming; Zhang, Huilai; Su, Hang; Jiang, Yongsheng; Ouyang, Weiwei; Ma, Lulin; Sun, Yan; Zhang, Feng; Lv, Jun; Guo, Yabing; Xu, Chongyuan; Qi, Junyuan; Wang, Li; Wang, Xiang; Liu, Zhen; Shen, Lin |
| Aug-2020 | The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial | Shi, Yuankai; Wu, Jianqiu; Wang, Zhen; Zhang, Liling; Wang, Zhao; Zhang, Mingzhi; Cen, Hong; Peng, Zhigang; Li, Yufu; Fan, Lei; Guo, Ye; Ma, Liping; Cui, Jie; Gao, Yuhuan; Yang, Haiyan; Zhang, Hongyu; Wang, Lin; Zhang, Weihua; Zhang, Huilai; Xie, Liping; Jiang, Ming; Zhou, Hui; Shuang, Yuerong; Su, Hang; Ke, Xiaoyan; Jin, Chuan; Du, Xin; Du, Xin; Liu, Li; Xi, Yaming; Ge, Zheng; Feng, Ru; Zhang, Yang; Zhou, Shengyu; Xie, Fan; Gao, Chao |
| 11-Aug-2023 | First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study | Zhong, Kaili; Shi, Yanyan; Gao, Yuhuan; Zhang, Huilai; Zhang, Mingzhi; Zhang, Qiaohua; Cen, Xinan; Xue, Mei; Qin, Yan; Zhao, Yu; Zhang, Liling; Liang, Rong; Wang, Ningju; Xie, Yan; Yang, Yu; Liu, Aichun; Bao, Huizheng; Wang, Jingwen; Cao, Baoping; Zhang, Wei; Zhang, Weijing |
| 20-May-2020 | Gls-010, a novel anti-PD-1 mAb in Chinese patients with relapsed or refractory classical Hodgkin lymphoma: Preliminary impressive result of a phase II clinical trial. | Song, Yuqin; Zhu, Jun; Lin, Ningjing; Zhang, Mingzhi; Bai, Hai; Liu, Hui; Cui, Jie; Ke, Xiaoyan; Zhang, Huilai; Liu, Lihong; Yan, Dongmei; Jiang, Yongsheng; Zang, Aimin; Qi, Junyuan; Wang, Li; Liu, Zhuogang; Xu, Bing; Zhang, Ying; Zhang, Zhihui; Meng, Haijin |
| Aug-2020 | GLS-010, a novel fully human anti-PD-1 mAb in patients with advanced tumor: Preliminary results of a Phase Ib clinical trial | Shen, Lin; Gong, Jifang; Song, Yuqin; Ye, Dingwei; Lu, Zhihao; Wang, Siyang; Peng, Peijian; Chen, Jianhua; Jiang, Ou; Zhang, Guojun; Bai, Yuxian; Pan, Jianji; Ma, Chunguang; Chen, Li; Ma, Yi; Li, Qi; Lu, Ping; Zhang, Lingli; Yin, Xianli; Gu, Shanzhi; Zhang, Huilai; Su, Hang; Jiang, Yongsheng; Cao, Bangwei; Han, Weiqing; Sun, Yan; Zhang, Feng; Ouyang, Weiwei; Dong, Haiying; Guo, Jianming; Guo, Yabing; Xu, Chongyuan; Qi, Junyuan; Wang, Li; Lv, Jun; Wang, Xiang; Chen, Chris; Li, Jing; Zheng, Yong; Jin, Ge; Yang, Yining; Zhao, Guodong; Yang, Fan; Xu, Kehui; Liang, Xiangying; Pan, Zhaoyang; Meng, Haijin |
| 2-Nov-2023 | Golidocitinib in Treating Refractory or Relapsed Peripheral T- Cell Lymphoma: Full Analysis of the Multinational Pivotal Study Results (JACKPOT8) | Song, Yuqin; Malpica, Luis; Cai, Qingqing; Zhao, Weili; Zhou, Keshu; Wu, Jianqiu; Zhang, Huilai; Ding, Kaiyang; Liu, Yao; Li, Zengjun; Mehta-Shah, Neha; Zhang, Liling; Zheng, Meifang; Jin, Jie; Yang, Haiyan; Shuang, Yuerong; Yoon, Dok Hyun; Gao, Sujun; Li, Wenyu; Zhai, Zhimin; Zou, Liqun; Xi, Yaming; Koh, Youngil; Li, Fei; Prince, Miles; Zhou, Hui; Lin, Lie; Liu, Hui; Yang, Zhenfan; Kim, Won Seog; Zhu, Jun |
| Sep-2021 | Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis | Lang, Mingxiao; Feng, Youqin; Meng, Xiangrui; Zhao, Jing; Song, Zheng; Qian, Zhengzi; Qiu, Lihua; Zhou, Shiyong; Liu, Xianming; Li, Lanfang; Yang, Haiyan; Song, Yuqin; Li, Wei; Zhang, Huilai |
| 2-Nov-2023 | Indirect Comparison of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL): An Updated Analysis with Long-Term Follow up | Song, Yuqin; Zhou, Keshu; Li, Dengju; Hu, Jianda; Zou, Dehui; Gao, Sujun; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lyu, Fangfang; Fang, Cheng; Xu, Sheng; Zhu, Jun |
| 2023 | Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma | Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun |
| 2023 | Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 15-Nov-2022 | Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael L.; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 4-Nov-2021 | A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China | Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun |
